Serum osteocalcin in rheumatoid arthritis and other inflammatory arthritides: relation between inflammatory activity and the effect of glucocorticoids and remission inducing drugs.

Osteocalcin, a vitamin K dependent protein synthesised by osteoblasts, was measured in serum by radioimmunoassay in patients with rheumatoid arthritis (n = 36) and seronegative spondyloarthropathies (n = 23). The serum osteocalcin levels were decreased in both patient groups compared with the levels measured in age and sex matched healthy controls. We found no relation between serum osteocalcin and the disease duration or inflammatory activity of the patients who were without drug treatment at the first examination. After administration of glucocorticoids (20 mg prednisolone a day) circulating osteocalcin decreased significantly after one week of treatment. During gradual reduction of the steroid dosage osteocalcin returned to pretreatment values. Treatment with non-steroidal anti-inflammatory drugs (NSAIDs) did not influence circulating osteocalcin. During treatment with chloroquine or penicillamine serum osteocalcin increased significantly, concomitant with a reduction of the acute phase reactants. Controversy persists about the abnormality of bone turnover in rheumatic diseases, but our data suggest that the overall bone turnover is decreased in patients with rheumatoid arthritis and other inflammatory arthritides.

[1]  J. Rastad,et al.  Serum osteocalcin levels in normal subjects and patients with primary hyperparathyroidism. , 2009, Experimental and clinical endocrinology.

[2]  L. Avioli Osteoporosis in rheumatoid arthritis. , 1987, Arthritis and rheumatism.

[3]  J. Lian,et al.  Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting. , 1984, The Journal of clinical endocrinology and metabolism.

[4]  P. Delmas,et al.  SERUM BONE GLA-PROTEIN: A SPECIFIC MARKER FOR BONE FORMATION IN POSTMENOPAUSAL OSTEOPOROSIS , 1984, The Lancet.

[5]  S. Epstein,et al.  DIFFERENCES IN SERUM BONE GLA PROTEIN WITH AGE AND SEX , 1984, The Lancet.

[6]  K. Mann,et al.  Effect of renal function on plasma levels of bone Gla-protein. , 1983, The Journal of clinical endocrinology and metabolism.

[7]  J. Lian,et al.  Serum osteocalcin in the treatment of inherited rickets with 1,25-dihydroxyvitamin D3. , 1983, The Journal of clinical endocrinology and metabolism.

[8]  J. Esdaile,et al.  Generalized skeletal response to 99mtechnetium methylene diphosphonate in rheumatoid arthritis. , 1982, The Journal of rheumatology.

[9]  I. Fogelman,et al.  Whole body retention of diphosphonate in rheumatoid arthritis. , 1982, The Journal of rheumatology.

[10]  P. Tothill,et al.  Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment. , 1982, British medical journal.

[11]  V. Wright,et al.  Comparison of serum 1,25-dihydroxycholecalciferol concentrations in rheumatoid arthritis and osteoarthrosis. , 1982, Annals of the rheumatic diseases.

[12]  P. Price,et al.  Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. , 1981, The Journal of biological chemistry.

[13]  R. Nuti,et al.  Pathophysiology of the adverse effects of glucoactive corticosteroids on calcium metabolism in man. , 1981, Journal of steroid biochemistry.

[14]  P. Price,et al.  1,25-Dihydroxyvitamin D3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells. , 1980, The Journal of biological chemistry.

[15]  L. Deftos,et al.  New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. , 1980, The Journal of clinical investigation.

[16]  K. Rosenspire,et al.  Investigation of the metabolic acitivity of bone in rheumatoid arthritis. , 1980, The Journal of rheumatology.

[17]  J. Lian,et al.  Carboxylated calcium-binding proteins and vitamin K. , 1980, The New England journal of medicine.

[18]  A. Tashjian,et al.  Biological activities of prostaglandin analogues and metabolites on bone in organ culture , 1977, Nature.

[19]  J. Poser,et al.  Characterization of a gamma-carboxyglutamic acid-containing protein from bone. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Lian,et al.  Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Poser,et al.  Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoids. , 1984, Metabolic bone disease & related research.

[22]  J. Poser,et al.  Characterization of a y-carboxyglutamic acid-containing protein from bone , 2022 .